Literature DB >> 34320056

High prevalence of psychiatric comorbidities in children and adolescents at a tertiary epilepsy center.

Maria Antonia Serra-Pinheiro1, Isabella D'andrea-Meira1,2, Abraão Iuri Medeiros Angelim1, Fernanda Alves Fonseca1, Nicolle Zimmermann1.   

Abstract

BACKGROUND: Epilepsy is highly comorbid with psychiatric disorders and a significant amount of the morbidity related to epilepsy is in fact a result of psychiatric comorbidities.
OBJECTIVE: To investigate the frequency of different psychiatric comorbidities in children with refractory epilepsy.
METHODS: We present preliminary observational data from a series of patients (n=82) examined in the psychiatric branch of a tertiary epilepsy center in Rio de Janeiro, Brazil. Patients were classified as presenting autism spectrum disorders, mood disorders, anxiety disorders, disruptive disorders, attention deficit hyperactivity disorder (ADHD), intellectual development disorder, psychotic episode, dissociative/conversive disorders or others. We determined the frequency of each disorder, along with demographic data, medications prescribed, electroencephalogram findings and additional medical examinations and consultations.
RESULTS: The most common comorbidities in our sample were autism spectrum disorders and ADHD. Antipsychotics and selective serotonin uptake inhibitors were the most commonly prescribed psychiatric medications.
CONCLUSIONS: Knowledge about the prevalence of such comorbidities may provide more targeted interventions in Psychiatry and Psychology services linked to epilepsy centers.

Entities:  

Mesh:

Year:  2021        PMID: 34320056     DOI: 10.1590/0004-282X-ANP-2020-0202

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  1 in total

1.  Psychiatric Symptoms and Parental Stress in Children and Adolescents With Epilepsy.

Authors:  Francesca Felicia Operto; Grazia Maria Giovanna Pastorino; Federica Pippa; Chiara Padovano; Valentina Vivenzio; Chiara Scuoppo; Ilaria Pistola; Giangennaro Coppola
Journal:  Front Neurol       Date:  2021-12-08       Impact factor: 4.003

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.